Nerve Growth Factor(Beijing Tiantan Hospital)

N/A

Report date: 2024/05/09 20:00:08

Base Information

Drug NameNerve Growth Factor(Beijing Tiantan Hospital)
Drug Alias NameNerve Growth Factor Encapsulated With 2-methacryloyloxyethyl Phosphorylcholine Nanocapsulesnerve growth factor (NGF) encapsulated with 2-methacryloyloxyethyl phosphorylcholine (MPC)MPC-NGF
ClassificationBiologics > Protein drugs > Non-recombinant cytokines
Mechanisms of ActionNeurons stimulants
TargetsNot applicable
Therapy Area/IndicationsAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesBeijing Tiantan Hospital, Capital Medical UniversityBeijing University Of Chemical TechnologyBeijing Healthunion Cardio-Cerebrovascular Disease Prevention and Treatment Foundation
China Registration ClassN/A

Develop Information

Active CompaniesBeijing University Of Chemical TechnologyBeijing Healthunion Cardio-Cerebrovascular Disease Prevention and Treatment FoundationBeijing Tiantan Hospital, Capital Medical University
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A